Login to Your Account



Pioneer Genentech Deserves Credit For Pipeline, Analyst Says

By Randall Osborne


Monday, April 21, 2003
Investors are likely to be all ears this week when Genentech Inc. hosts its annual meeting with stockholders. A recent earnings report and other news from the pioneering company - the industry's oldest, often cited by analysts as an example of what a biotechnology firm can be - seem certain to drum up even more interest than usual in the much-watched firm. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription